Literature DB >> 24154594

Application of recombinant Cryptosporidium parvum P23 for isolation and prevention.

Zahra Omidian1, Elahe Ebrahimzadeh, Parisa Shahbazi, Zeinab Asghari, Parviz Shayan.   

Abstract

Cryptosporidium parvum is a coccidian protozoan that causes diarrhea in immunocompromised humans and newborn animals. Billions of oocysts of C. parvum can be released from the infected calves and can contaminate the environment. The severity of the disease depends on the immunological status of the individual. Oocysts of Cryptosporidium are extremely resistant to many environmental stresses, and no effective disinfectant and curative agent against this organism is available. In our study, recombinant C. parvum P23 was prepared for application in the isolation and prevention of cryptosporidiosis. P23 is a glycoprotein that belongs to a family of protein of 23-27 kDa and is believed to be expressed in the different life stages of the parasite. Immunostaining analysis using the indirect fluorescent antibody test showed that P23 could be recognized on the surface of the oocysts. The antibody prepared in rabbit against P23 was bound to Sepharose 4B and used for the isolation of oocysts. The results showed that the prepared column was able to bind specifically only the oocysts. The effect of specific recombinant C. parvum IgY antibody against infection with C. parvum was examined in a mouse model. For this aim, purified egg yolk antibody prepared from immunized hens was used to analyze the protective effect of recombinant P23 specific antibody in immunosuppressed adult mice. The results showed more than 70% reduction in oocyst shedding after challenge with 1 × 10(4) oocysts. These results support previous studies of other investigators regarding the protective effect of P23 as an antigen against C. parvum infection and showed that it could be possible to design a passive immunization strategy against C. parvum based on the anti-P23 yolk antibody in animals and immunosuppressed humans.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24154594     DOI: 10.1007/s00436-013-3648-0

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  46 in total

1.  ImmunoCard STAT! cartridge antigen detection assay compared to microplate enzyme immunoassay and modified Kinyoun's acid-fast staining technique for detection of Cryptosporidium in fecal specimens.

Authors:  Amal Abdul-Rasheed El-Moamly; Mohamed Aly El-Sweify
Journal:  Parasitol Res       Date:  2011-08-14       Impact factor: 2.289

2.  Distribution of Cryptosporidium oocysts and Giardia cysts in water above and below the normal limit of detection.

Authors:  Jerry E Ongerth; Frhat M A Saaed
Journal:  Parasitol Res       Date:  2012-10-11       Impact factor: 2.289

3.  A cloned gene of Cryptosporidium parvum encodes neutralization-sensitive epitopes.

Authors:  L E Perryman; D P Jasmer; M W Riggs; S G Bohnet; T C McGuire; M J Arrowood
Journal:  Mol Biochem Parasitol       Date:  1996-10-01       Impact factor: 1.759

4.  Staining of cryptosporidia by a modified Ziehl-Neelsen technique.

Authors:  S A Henriksen; J F Pohlenz
Journal:  Acta Vet Scand       Date:  1981       Impact factor: 1.695

5.  Protection of calves against cryptosporidiosis with immune bovine colostrum induced by a Cryptosporidium parvum recombinant protein.

Authors:  L E Perryman; S J Kapil; M L Jones; E L Hunt
Journal:  Vaccine       Date:  1999-04-23       Impact factor: 3.641

6.  Quantitative and qualitative comparisons of Cryptosporidium faecal purification procedures for the isolation of oocysts suitable for proteomic analysis.

Authors:  Q Truong; B C Ferrari
Journal:  Int J Parasitol       Date:  2006-03-31       Impact factor: 3.981

7.  Protection of calves with a vaccine against Cryptosporidium parvum.

Authors:  J A Harp; J P Goff
Journal:  J Parasitol       Date:  1995-02       Impact factor: 1.276

8.  Antigens of Cryptosporidium sporozoites recognized by immune sera of infected animals and humans.

Authors:  J R Mead; M J Arrowood; C R Sterling
Journal:  J Parasitol       Date:  1988-02       Impact factor: 1.276

9.  Changes in mouse circulating leukocyte numbers in C57BL/6 mice immunosuppressed with dexamethasone for Cryptosporidium parvum oocyst production.

Authors:  Thomas A Miller; Frank W Schaefer
Journal:  Vet Parasitol       Date:  2007-09-27       Impact factor: 2.738

10.  Detection of antibodies to a recombinant Cryptosporidium parvum p23 in serum and feces from neonatal calves.

Authors:  Hsu-Fong Wang; John B Swain; Thomas E Besser; Douglas Jasmer; Carol R Wyatt
Journal:  J Parasitol       Date:  2003-10       Impact factor: 1.276

View more
  5 in total

1.  Construction of a recombinant food-grade Lactococcus lactis expressing P23 protein of Cryptosporidium parvum.

Authors:  Xuehan Liu; Lei Deng; Wei Li; Zhijun Zhong; Ziyao Zhou; Guangneng Peng
Journal:  Folia Microbiol (Praha)       Date:  2022-03-24       Impact factor: 2.629

2.  Isolation of Small Number of Cryptosporidium parvum Oocyst Using Immunochromatography.

Authors:  Elahe Ebrahimzade; Parviz Shayan; Zeinab Asghari; Sedighe Jafari; Zahra Omidian
Journal:  Iran J Parasitol       Date:  2014 Oct-Dec       Impact factor: 1.012

3.  Cryptosporidium suis infection in post-weaned and adult pigs in Shaanxi province, northwestern China.

Authors:  Qing Lin; Xing-Ye Wang; Jian-Wen Chen; Ling Ding; Guang-Hui Zhao
Journal:  Korean J Parasitol       Date:  2015-02-27       Impact factor: 1.341

4.  The Protective Effect of Artemisia spicigera Ethanolic Extract against Cryptosporidium parvum Infection in Immunosuppressed Mice.

Authors:  Parisa Shahbazi; Ahmad Nematollahi; Sanaz Arshadi; Hosein Hashemzadeh Farhang; Amir Ali Shahbazfar
Journal:  Iran J Parasitol       Date:  2021 Apr-Jun       Impact factor: 1.012

Review 5.  Immunoglobulin Y for Potential Diagnostic and Therapeutic Applications in Infectious Diseases.

Authors:  Lucia Lee; Kate Samardzic; Michael Wallach; Lyn R Frumkin; Daria Mochly-Rosen
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.